Order Article Reprints

Alexeeva EI, Tsulukiya IT, Dvoryakovskaya TM, Kudlay DA, Kriulin IA, Botova MS, Kondratyeva NM, Krekhova EA, Shingarova MS, Kokina MY, et al. Can We Successfully Discontinue Anti-Tumor Necrosis Factor-α Treatment in Children with Non-Systemic Juvenile Idiopathic Arthritis? The Experience of a Tertiary Center. Biomedicines. 2025; 13(10):2329. https://doi.org/10.3390/biomedicines13102329

Alexeeva, Ekaterina I., Irina T. Tsulukiya, Tatyana M. Dvoryakovskaya, Dmitry A. Kudlay, Ivan A. Kriulin, Maria S. Botova, Natalya M. Kondratyeva, Elizaveta A. Krekhova, Meiri Sh. Shingarova, Maria Y. Kokina, and et al. 2025. "Can We Successfully Discontinue Anti-Tumor Necrosis Factor-α Treatment in Children with Non-Systemic Juvenile Idiopathic Arthritis? The Experience of a Tertiary Center" Biomedicines 13, no. 10: 2329. https://doi.org/10.3390/biomedicines13102329

Alexeeva, E. I., Tsulukiya, I. T., Dvoryakovskaya, T. M., Kudlay, D. A., Kriulin, I. A., Botova, M. S., Kondratyeva, N. M., Krekhova, E. A., Shingarova, M. S., Kokina, M. Y., Fetisova, A. N., Isaeva, K. B., Chomakhidze, A. M., Chibisova, C. V., & Kostik, M. M. (2025). Can We Successfully Discontinue Anti-Tumor Necrosis Factor-α Treatment in Children with Non-Systemic Juvenile Idiopathic Arthritis? The Experience of a Tertiary Center. Biomedicines, 13(10), 2329. https://doi.org/10.3390/biomedicines13102329